Monday, February 26, 2024
Seek Labs is developing next generation molecular diagnostics technologies that have the potential to revolutionize the detection and treatment of diseases. Point of care diagnostics is currently limited by expensive technologies, the need for specialized equipment, training and temperature controls. Seek has eliminated these barriers, vastly expanding the definition of point of care and opening an array of new global markets for diagnostics and treatments of disease on a global scale. A single device the size of a credit card can now process a sample and generate a test result in under 20 minutes, anytime, anyplace and anywhere.
CEO/Top Company Official
Lead Product in Development
SeekIt molecular diagnostic platform. Platform is a single device that performs DNA/RNA extraction, amplification, testing and communication - all without any additional equipment, training, electricity or temperature control.
Development Phase of Primary Product
Number Of Unlicensed Products